Codetta Biosciences Announces $15 Million in Series A Financing
Codetta Biosciences, the pioneer in digital spatial polymerase chain reaction (dsPCR) and digital spatial immuno polymerase chain reaction (dsiPCR), announced today that it has raised $15 million in Series A financing, led by Anzu Partners with additional funding from Genoa Ventures and VC23 LLC. Codetta will use the funds to accelerate the development of its multi-omic dsPCR platform and aggressively scale up its workforce in R&D, engineering, marketing, and business administration.